Investigation of Novel Triterpenoids as New Potent AMPK Activators for the Treatment of Insulin Resistant States

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/535930

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Type 2 Diabetes has major economic and health implications. Current medications are inadequate or have serious adverse effects. Triterpenoids have been used in traditional medicines for various diseases. This project builds on our recent discovery of novel triterpenoids with antidiabetic properties to investigate their efficacy and mechanisms of action. The results will provide valuable information about this class of molecules as potential new therapeutics for Type 2 diabetes.

Funded Activity Details

Start Date: 01-01-2009

End Date: 01-01-2012

Funding Scheme: NHMRC Project Grants

Funding Amount: $574,075.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Therapies And Therapeutic Technology

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

AMPK activators | Dyslipidaemia | GLUT4 Translocation and Glucose Uptake | Insulin Resistance and Obesity | Insulin resistance | Metabolic Syndrome | New drug targets | Novel Therapeutic Compounds | Obesity | Type 2 Diabetes

Related Links